Pricing Agreement
Exhibit 1.2
NatWest Markets Securities Inc.
000 Xxxxxxxxxx Xxxxxxxxx
Xxxxxxxx, XX 00000
Xxxxxx Xxxxxx of America
Credit Suisse Securities (USA) LLC
Eleven Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Xxxxxx Xxxxxx of America
As Representatives of the several
Underwriters named in Schedule I hereto,
October 29, 2019
Ladies and Gentlemen:
The Royal Bank of Scotland Group plc, a public limited company incorporated under the laws of, and registered in, Scotland (the “Company”), proposes, subject to the terms and conditions stated herein and in the Underwriting Agreement, dated October 29, 2019 (the “Underwriting Agreement”) among the Company on the one hand and the several Underwriters on the other hand, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), or to purchasers procured by them, the securities specified in Schedule II hereto (the “Notes”).
Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Pricing Agreement, except that each representation and warranty which refers to the Disclosure Package and/or the Prospectus in Section 2 of the Underwriting Agreement shall be deemed to be a representation or warranty as of the date of the Underwriting Agreement in relation to the Disclosure Package and/or the Prospectus (each as therein defined), as the case may be, and also a representation and warranty as of the date of this Pricing Agreement in relation to the Disclosure Package and/or the Prospectus (as amended or supplemented), as the case may be, relating to the Notes which are the subject of this Pricing Agreement. Each reference to the Representatives herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herein as therein defined. The Representatives designated to act on behalf of themselves and on behalf of each of the Underwriters of the Notes pursuant to Section 12 of the Underwriting Agreement and the address of the Representatives referred to in such Section 12 are set forth at the end of Schedule II hereto.
An amendment to the Registration Statement, or a supplement to the Prospectus, as the case may be, relating to the Notes, in the form heretofore delivered to you is now proposed to be filed with the Commission.
Subject to the terms and conditions set forth herein (including Schedules I and II hereto) and in the Underwriting Agreement incorporated herein by reference, the Company agrees to issue and sell to each of the Underwriters, or to purchasers procured by them, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, or to procure purchasers to purchase from the Company, at the time and place and at the purchase price to the Underwriters set forth in Schedule II hereto, the principal amount of Notes set forth opposite the name of such Underwriter in Schedule I hereto.
If the foregoing is in accordance with your
understanding, please sign and return to us
one counterpart hereof, and upon acceptance hereof by you, on behalf of each of the Underwriters, this letter and such acceptance
hereof, including the provisions of the Underwriting Agreement incorporated herein by reference, shall constitute a binding agreement
between each of the Underwriters and the Company. It is understood that your acceptance of this letter on behalf of each of the
Underwriters is or will be pursuant to the authority set forth in a form of Agreement among Underwriters, the form of which shall
be submitted to the Company for examination upon request, but without warranty on the part of the Representatives as to the authority
of the signers thereof.
[The rest of this page is intentionally left blank.]
2
Very truly yours, | ||||
THE ROYAL BANK OF SCOTLAND GROUP PLC | ||||
By: | /s/ Xxxxx Xxxxx | |||
Name: | Xxxxx Xxxxx | |||
Title: | Head of Treasury Markets |
\[The rest of this page is intentionally left blank.]
3
Accepted as of the date hereof:
NatWest Markets Securities Inc.
By: | /s/ Xxxx Mijne | ||
Name: | Xxxx Mijne | ||
Title: | Director |
Credit Suisse Securities (USA) LLC
By: | /s/ Xxxxxx Xxxxxx | ||
Name: | Xxxxxx Xxxxxx | ||
Title: | MD |
For themselves and as Representatives of the several Underwriters
4
SCHEDULE I
Principal Amount of Notes to be Purchased | ||
BofA Securities, Inc. | $187,500,000 | |
Credit Suisse Securities (USA) LLC | $187,500,000 | |
NatWest Markets Securities Inc. | $187,500,000 | |
RBC Capital Markets LLC | $187,500,000 | |
Total: | $750,000,000 |
5
SCHEDULE II
Capitalized terms used herein, unless otherwise stated, shall have the meaning set forth in the Underwriting Agreement.
Title of Notes:
$750,000,000 Fixed-to-Fixed Reset Rate Subordinated Tier 2 Notes due 2029 (the “Notes”)
Aggregate principal amount of Notes:
$750,000,000 principal amount of the Notes
Price to Public:
100% of the principal amount of the Notes
Purchase Price by Underwriters:
99.580% of the principal amount of the Notes
Underwriting Commission:
0.420% for the Notes
Form of Securities:
Book-entry only form represented by one or more global notes deposited with a custodian for DTC, Euroclear Bank SA/NV and Clearstream Banking, société anonyme, as the case may be.
Specified funds for payment of purchase price:
Wire transfer of immediately available funds
Applicable time:
3:10 p.m. (New York time), October 29, 2019
Time of Delivery:
9:30 a.m. (New York time), November 1, 2019
Indenture:
Subordinated Debt Securities Indenture dated as of December 4, 2012, as amended by a first supplemental indenture dated December 4, 2012 and a fourth supplemental indenture dated May 28, 2014, between the Company and The Bank of New York Mellon, acting through its London Branch, as Trustee, and as further amended and supplemented by a fifth supplemental indenture to be dated on or around November 1, 2019.
6
Maturity Date:
November 1, 2029 for the Notes
Interest Rate:
- | from (and including) November 1, 2019, to (but excluding) November 1, 2024, 3.754% per annum; and |
- | from (and including) November 1, 2024 to (but excluding) maturity, a rate per annum equal to the applicable U.S. Treasury Rate as determined by the Calculation Agent on the Reset Determination Date, plus 2.100%. |
Interest Payment Dates:
- | interest on the Notes will be payable semi-annually in arrear on May 1 and November 1 of each year, beginning on May 1, 2020, to (and including) maturity. |
Regular Record Dates:
- | interest record dates for the Notes will be the 15th day of each April and October of each year, whether or not a business day, immediately preceding the relevant Interest Payment Date. |
Interest Rate Reset Date:
Interest will be reset on November 1, 2024.
Redemption Provisions:
The Notes may be redeemed as described in the Prospectus.
U.K. Bail-In Power:
The Notes may be subject to the U.K. bail-in power as described in the Prospectus.
Sinking Fund Provisions:
No sinking fund provisions.
Closing location for delivery of Notes:
Offices of Xxxxx Xxxx & Xxxxxxxx
London LLP, 0 Xxxxxxxxxxxx Xxxxxx
Xxxxxx XX0X 0XX, Xxxxxx Xxxxxxx
Names and addresses of Representatives:
Designated Representatives:
NatWest Markets Securities Inc.
Credit Suisse Securities (USA) LLC
Address for Notices:
NatWest Markets Securities Inc.
7
000 Xxxxxxxxxx Xxxxxxxxx
Xxxxxxxx, XX 00000
Xxxxxx Xxxxxx of America
Credit Suisse Securities (USA) LLC
Eleven Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Xxxxxx Xxxxxx of America
CUSIP:
000000XX0 for the Notes
ISIN:
US780097BM20 for the Notes
Stock Exchange Listing:
The Company intends to apply to list the Notes on the New York Stock Exchange in accordance with its rules.
Other Terms:
The Notes will have additional terms as more fully described in the Disclosure Package and the Prospectus and shall be governed by the Indenture.
8